Erythropoietic protoporphyria is a genetic condition where protoporphyrins accumulate in red blood cells. This accumulation causes severe sensitivity to sunlight, resulting in acute pain, though without blistering. Additionally, there's a risk of liver disease associated with this condition. Symptoms typically begin in childhood, marked by immediate pain and crying upon exposure to bright sunlight. EPP tends to worsen during spring and summer months.
The stock we are bringing to your attention today is that of Australia-based Clinuvel Pharmaceuticals Limited (CLVLY.OB), which has an approved photoprotective drug.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com